These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 11396943)
1. Identification of calnexin as a binding protein for Amadori-modified glycated albumin. Wu VY; Shearman CW; Cohen MP Biochem Biophys Res Commun; 2001 Jun; 284(3):602-6. PubMed ID: 11396943 [TBL] [Abstract][Full Text] [Related]
2. Evidence for a ligand receptor system mediating the biologic effects of glycated albumin in glomerular mesangial cells. Wu VY; Cohen MP Biochem Biophys Res Commun; 1995 Feb; 207(2):521-8. PubMed ID: 7864838 [TBL] [Abstract][Full Text] [Related]
3. Receptors specific for Amadori-modified glycated albumin on murine endothelial cells. Wu VY; Cohen MP Biochem Biophys Res Commun; 1994 Jan; 198(2):734-9. PubMed ID: 7507669 [TBL] [Abstract][Full Text] [Related]
4. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system. Ziyadeh FN; Han DC; Cohen JA; Guo J; Cohen MP Kidney Int; 1998 Mar; 53(3):631-8. PubMed ID: 9507208 [TBL] [Abstract][Full Text] [Related]
5. Identification of aortic endothelial cell binding proteins for Amadori adducts in glycated albumin. Wu VY; Cohen MP Biochem Biophys Res Commun; 1993 Jun; 193(3):1131-6. PubMed ID: 8323537 [TBL] [Abstract][Full Text] [Related]
6. Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription. Cohen MP; Hud E; Wu VY; Ziyadeh FN Mol Cell Biochem; 1995 Oct; 151(1):61-7. PubMed ID: 8584015 [TBL] [Abstract][Full Text] [Related]
7. Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy. Ziyadeh FN; Cohen MP Mol Cell Biochem; 1993 Aug; 125(1):19-25. PubMed ID: 8264568 [TBL] [Abstract][Full Text] [Related]
9. Development of Diagnostic Fragment Ion Library for Glycated Peptides of Human Serum Albumin: Targeted Quantification in Prediabetic, Diabetic, and Microalbuminuria Plasma by Parallel Reaction Monitoring, SWATH, and MSE. Korwar AM; Vannuruswamy G; Jagadeeshaprasad MG; Jayaramaiah RH; Bhat S; Regin BS; Ramaswamy S; Giri AP; Mohan V; Balasubramanyam M; Kulkarni MJ Mol Cell Proteomics; 2015 Aug; 14(8):2150-9. PubMed ID: 26023067 [TBL] [Abstract][Full Text] [Related]
10. ERK mediates effects of glycated albumin in mesangial cells. Cohen MP; Shea E; Shearman CW Biochem Biophys Res Commun; 2001 May; 283(3):641-3. PubMed ID: 11341772 [TBL] [Abstract][Full Text] [Related]
11. Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse. Cohen MP; Masson N; Hud E; Ziyadeh F; Han DC; Clements RS Exp Nephrol; 2000; 8(3):135-43. PubMed ID: 10810230 [TBL] [Abstract][Full Text] [Related]
12. Glycated albumin stimulates fibronectin and collagen IV production by glomerular endothelial cells under normoglycemic conditions. Cohen MP; Wu VY; Cohen JA Biochem Biophys Res Commun; 1997 Oct; 239(1):91-4. PubMed ID: 9345275 [TBL] [Abstract][Full Text] [Related]
13. Glycated albumin stimulation of PKC-beta activity is linked to increased collagen IV in mesangial cells. Cohen MP; Ziyadeh FN; Lautenslager GT; Cohen JA; Shearman CW Am J Physiol; 1999 May; 276(5):F684-90. PubMed ID: 10330050 [TBL] [Abstract][Full Text] [Related]
14. Glycated albumin induces superoxide generation in mesangial cells. Yoo CW; Song CY; Kim BC; Hong HK; Lee HS Cell Physiol Biochem; 2004; 14(4-6):361-8. PubMed ID: 15319540 [TBL] [Abstract][Full Text] [Related]
15. Expression of fructosyllysine receptors on human monocytes and monocyte-like cell lines. Salazar R; Brandt R; Krantz S Biochim Biophys Acta; 1995 Apr; 1266(1):57-63. PubMed ID: 7718622 [TBL] [Abstract][Full Text] [Related]
16. Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Wa C; Cerny RL; Clarke WA; Hage DS Clin Chim Acta; 2007 Oct; 385(1-2):48-60. PubMed ID: 17707360 [TBL] [Abstract][Full Text] [Related]
17. Amadori products promote cellular senescence activating insulin-like growth factor-1 receptor and down-regulating the antioxidant enzyme catalase. Del Nogal-Ávila M; Troyano-Suárez N; Román-García P; Cannata-Andía JB; Rodriguez-Puyol M; Rodriguez-Puyol D; Kuro-O M; Ruiz-Torres MP Int J Biochem Cell Biol; 2013 Jul; 45(7):1255-64. PubMed ID: 23579096 [TBL] [Abstract][Full Text] [Related]
18. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy. Cohen MP; Sharma K; Jin Y; Hud E; Wu VY; Tomaszewski J; Ziyadeh FN J Clin Invest; 1995 May; 95(5):2338-45. PubMed ID: 7738197 [TBL] [Abstract][Full Text] [Related]
19. Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy. Cohen MP; Ziyadeh FN J Am Soc Nephrol; 1996 Feb; 7(2):183-90. PubMed ID: 8785386 [TBL] [Abstract][Full Text] [Related]
20. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]